Top Markets
#1 Islamic Coin Islamic Coin +152.31%
#2 Bitway Bitway +45.94%
#3 Starpower Starpower +39.28%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +32.39%
#5 aelf aelf +26.47%
#6 Pons Pons +26.20%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.27%
#8 SkyAI SkyAI +18.19%
#9 Decred Decred +16.18%
#10 Ocean Protocol Ocean Protocol +15.29%
Coin of the day
Islamic Coin Islamic Coin
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
Medivir AB (publ) Medivir AB (publ)

Medivir AB (publ)

MVIR-B
शेयरों में रैंक #29651
Medivir AB (publ) is a pharmaceutical company established in 1987 and... Medivir AB (publ) is a pharmaceutical company established in 1987 and headquartered in Huddinge, Sweden. It is dedicated to the research, development, and global commercialization of medicines, with a primary focus on oncology. The company currently markets Zoviduo (formerly Xerclear) for the treatment of labial herpes. Its robust development pipeline includes Remetinostat, targeting MF cutaneous T-cell lymphoma and basal cell carcinoma; MIV-818, aimed at liver cancer; and MIV-711, being advanced for osteoarthritis. Additionally, Medivir is progressing Birinapant and IGM-8444 for various solid tumor indications. Collaborative efforts are also key to its strategy, including a research partnership with SciLifeLab's Drug Discovery and Development Platform to discover antivirals for SARS CoV-2, alongside licensing agreements with Tango Therapeutics for a preclinical research program and with Ubiquigent Limited for the USP7 preclinical research program.
शेयर मूल्य
$0.68377137
अंतिम समन्वयन: 2023-05-23
मार्केट कैप
$20.23M
बदलाव (1 दिन)
-0.60%
बदलाव (1 वर्ष)
0.00%
देश
SE
व्यापार Medivir AB (publ) (MVIR-B)

श्रेणी

Healthcare
Medivir AB (publ) (MVIR-B) के लिए P/B अनुपात
2026 को P/B अनुपात TTM: 0
Medivir AB (publ) की नवीनतम वित्तीय रिपोर्ट और शेयर मूल्य के अनुसार, कंपनी का वर्तमान P/B अनुपात (TTM) 0 है। 2026 के अंत में, कंपनी का P/B अनुपात 0 था।
Medivir AB (publ) के लिए 2026 से 2026 तक P/B अनुपात का इतिहास
हर वर्ष के अंत में P/B अनुपात
वर्ष P/B अनुपात परिवर्तन
प्रदान की गई तारीखों के लिए पर्याप्त डेटा नहीं।
समान कंपनियों या प्रतिस्पर्धियों के लिए P/B अनुपात
कंपनी P/B अनुपात P/B अनुपात में अंतर देश
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR